Background:Non-alcoholic fatty liver disease(NAFLD)and inflammatory bowel disease(IBD)have shown similar worsening epidemic patterns globally and shared various overlapping pathophysiological mechanisms.However,evidence on the relationship between NAFLD and IBD risk is lacking.We aimed to investigate the associations between long-term risk of incident IBD and NAFLD in a large prospective cohort. Methods:Participants from the United Kingdom Biobank cohort(https://biobank.ndph.ox.ac.uk/)who were free of IBD and alcoholic liver disease at baseline were enrolled.Baseline non-alcoholic fatty liver degree was measured by the well-established fatty liver index(FLI).The outcomes of interest included incident IBD,ulcerative colitis(UC),and Crohn's disease(CD).Multivariable Cox proportional hazard regression was used to calculate hazard ratios(HRs)and 95％confidence intervals(CIs). Results:Among 418,721 participants(mean FLI:48.11±30.11),160,807(38.40％)participants were diagnosed as NAFLD at baseline.During a median of 12.4 years'follow-up,2346 incident IBD cases(1545 UC,653 CD,and 148 IBD-unclassified)were identified.Due to limited events,those IBD-unclassified were combined in UC or CD when examining the associated risk of UC or CD,separately.Compared with the lowest quartile of FLI,the highest quartile showed a separately 36.00％,25.00％,and 58.00％higher risk of incident IBD(HRQ4 vs.Q1=1.36,95％CI:1.19-1.55,P trend＜0.001),UC(HR Q4 vs.Q1=1.25,95％CI:1.07-1.46,P trend=0.047),and CD(HR Q4 vs Q1=1.58,95％CI:1.26-1.97,P trend＜0.001)after multivariable adjustment.Q1=1.58,95％CI:1.26-1.97,P trend＜0.001)after multivariable adjustment.Compared with non-NAFLD,NAFLD participants had a significantly higher risk of incident IBD(HR=1.13,95％CI:1.04-1.24)and CD(HR=1.36,95％CI:1.17-1.58). Conclusions:Higher degree of non-alcoholic fatty liver is associated with increased risk of incident IBD.Interventions aimed at improving NAFLD may be a potential targeted strategy for the detection and treatment of IBD.
Qian Zhang;Si Liu;Jing Wu;Shengtao Zhu;Yongdong Wu;Shanshan Wu;Shutian Zhang
Department of Gastroenterology,Beijing Friendship Hospital,Capital Medical University,National Clinical Research Center for Digestive Disease,Beijing Digestive Disease Center,Beijing Key Laboratory for Precancerous Lesion of Digestive Disease,Beijing 100050,China
Non-alcoholic fatty liver disease;Inflammatory bowel disease;Ulcerative colitis;Crohn's disease;Cohort study
《中华医学杂志（英文版）》 2024 (014)
1705-1714 / 10
This work was supported by grants from the National Natural Science Foundation of China(No.82100571)and the Beijing Science and Technology Project(No.Z191100006619083).
10.1097/CM9.0000000000002859
评论